New York, Jan 18, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Artificial Intelligence in Diabetes Management Market Research Report By Device, By Technique – Global Forecast to 2025 – Cumulative Effects of COVID-19”. – https://www.reportlinker.com/p06007552/?utm_source=GNW
Market Statistics:
The report provides market sizes and forecasts for five major currencies – USD, EUR, GBP, JPY and AUD. This helps business leaders make better decisions when money exchange data is available.
1. The global market for artificial intelligence in diabetes management is projected to grow from US $ 347.73 million in 2020 to US $ 1,275.42 million by the end of 2025.
2. The global market for artificial intelligence in diabetes management is expected to grow from EUR 304.90 million in 2020 to EUR 1,118.31 million by the end of 2025.
3. Global Artificial Intelligence in Diabetes Management Market is projected to grow from £ 271.05M in 2020 to £ 994.18M by the end of 2025.
4. The global artificial intelligence in diabetes management market is projected to grow from JPY37,112.36 million in 2020 to JPY136,120.28 million by the end of 2025.
5. Global Artificial Intelligence in Diabetes Management Market is projected to grow from A $ 504.96 million in 2020 to A $ 1,852.08 million by the end of 2025.
Market segmentation & coverage:
In this research report, artificial intelligence in diabetes management is categorized in order to forecast revenue and analyze trends in each of the following sub-markets:
Based on the device, artificial intelligence in the diabetes management market for diagnostic devices, glucose monitors, and insulin delivery devices has been studied.
Based on the technique, the artificial intelligence in diabetes management market has been studied using case-based thinking and intelligent data analysis.
Based on the geography, the Artificial Intelligence in Diabetes Management market in America, Asia-Pacific, Europe, Middle East and Africa has been studied. The American region has been studied in Argentina, Brazil, Canada, Mexico, and the United States. The Asia Pacific region has been studied in Australia, China, India, Indonesia, Japan, Malaysia, the Philippines, South Korea, and Thailand. The region studied is Europe, Middle East, and Africa in France, Germany, Italy, the Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, the United Arab Emirates, and the United Kingdom.
Company usability profiles:
The report delves into the recent major developments by the leading vendors and innovation profiles in the global Artificial Intelligence in Diabetes Management Market, including Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, Diabnext, DreaMed Diabetes, Ltd. Eyenuk, Inc., F. Hoffmann-La Roche Ltd., HCL Technologies Limited, IBM Corporation, Karger AG, Medtronic PLC, Nasdaq Inc., Novartis AG, Novo Nordisk A / S, Sanofi SA, Virta Health Corp., Vodafone Group PLC, whisk and xbird GmbH.
Cumulative Effects of COVID-19:
COVID-19 is an unparalleled global public health emergency that affects almost all industries. Therefore, the long-term effects will affect industry growth over the forecast period. Our ongoing research expands our research framework to ensure that underlying COVID-19 issues and possible pathways forward are considered. The report provides insights into COVID-19, taking into account changes in consumer behavior and demand, purchasing patterns, supply chain diversion, the dynamics of current market forces and significant government interventions. The updated study offers insights, analysis, estimates and projections considering the impact of COVID-19 on the market.
360iResearch ™ FPNV positioning matrix:
The 360iResearch ™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Diabetes Management market based on business strategy (business growth, industry coverage, financial profitability, and channel support) and product satisfaction (value for money, ease of use), product features, and Customer support) that help companies make decisions and understand the competitive landscape.
Competitive strategic window for 360iResearch ™:
The 360iResearch ™ Competitive Strategic Window analyzes the competitive landscape in terms of markets, applications and regions. The 360iResearch ™ competitive strategic window helps the vendor define an alignment or correspondence between its capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or low cost opportunity for vendors to apply successive merger and acquisition strategies, geographic expansion, research and development, and new product introduction strategies to pursue further business expansion and growth.
The report provides insights into the following notices:
1. Market Penetration: Provides comprehensive information on the market offered by the major players
2. Market Development: Provides detailed information on lucrative emerging countries and analyzes the markets
3. Market Diversification: Provides detailed information on new product launches, untapped regions, recent developments and investments
4. Competitive Assessment & Intelligence: Provides a comprehensive assessment of the market shares, strategies, products and manufacturing capabilities of leading companies
5. Product development and innovation: Provides intelligent insights into future technologies, R&D activities and new product developments
The report answers questions like:
1. What is the market size and forecast of the global Artificial Intelligence in Diabetes Management Market?
2. What are the restraining factors & impact of COVID-19 affecting the global Artificial Intelligence in Diabetes Management Market during the forecast period?
3. Which products / segments / applications / areas should be invested in in the forecast period in the global Artificial Intelligence in Diabetes Management market?
4. What is the strategic competitive window for opportunities in the global Artificial Intelligence in Diabetes Management Market?
5. What are the technology trends and legal framework conditions in the global market for artificial intelligence in diabetes management?
6. What modes and strategic steps are considered appropriate for entering the global Artificial Intelligence in Diabetes Management market?
Read the full report: https://www.reportlinker.com/p06007552/?utm_source=GNW
Via report linker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can get all of the market research you need – instantly in one place.
__________________________
Clare: clare@reportlinker.com USA: (339) -368-6001 Intl: +1 339-368-6001
